Mirum Pharmaceuticals, Inc. has grown revenue 75% a year over three years. Revenue growth, 3-year annual rate: +75% (Biotechnology median +17%). Years of annual history on file: 7, FY2019 to FY2025, as filed.

MIRMMirum Pharmaceuticals, Inc.

Healthcare

$85.96+16% 1Y

$85.96

$64.1052 weeks$122.04

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +44% year on year, but operating margin narrowing (−115.8 points).

1 good, 1 to watch, 1 without data

Revenue trend+44% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction−115.8 points operating

Trailing-twelve-month operating margin, -129.8% now against -14.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.